arrow
H

Harry Iland

the university of sydney
H指数:22
被引数:3,440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

ALLG APML5:三氧化二砷口服生物利用度及安全性评估,评估时间在APL巩固治疗期间

2025-01-281
OA
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
2023-06-055
OAAI
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
2015-09-01129
PREAI